BCPC
Balchem Corp Materials Chemicals & Allied Products Russell 3000
$169.98Close
$5.4BMarket cap
$146.46 – $183.2652-week range
Mid-januaryNext report · estimated
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Lagging the market RS 48 · weaker than 52% of stocks over 12 months
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
down 4.0%
price change
1mo
up 3.0%
price change
12-month return
up 11%
market up 11% ·
its own 0%
F-score
9 / 9
Exceptional
Altman Z
9.71
Low risk
P/E
35.2×
price / earnings
PEG
1.68
P/E / EPS growth
P/B
4.3×
price / book
Earnings yield
up 3.9%
EBIT / enterprise value
Cheaper than
50%
of the market · around average
Revenue growth
up 9%
year on year
EPS growth
up 18%
latest quarter · -0 pts
Sales growth
up 9%
latest quarter · -3 pts
ROE
up 13%
return on equity
Free cash margin
up 21%
$216.6M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
-0.3×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- no new shares issued
- gross margin widened
- assets working harder
Trade setup
ATR%
2.1%
$3.62 a day · 2×ATR $162.74
RS
48 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
1.0×
vs 50-day average
Up/down volume
1.17
50 sessions
Implied move
—
no scheduled report
Trend template · 4 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 23, 2026
Results reaction
Oct 23, 2026-2% vs market2 sessions after results
Financials
- Gross 36%
- Net 15%
- Free cash 21%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $703.6M | $799.0M | $942.4M | $922.4M | $953.7M | $1.0B |
| Gross margin | 32% | 30% | 30% | 33% | 35% | 36% |
| Operating income | $111.1M | $127.5M | $145.2M | $159.2M | $182.9M | $209.3M |
| Net income | $84.6M | $96.1M | $105.4M | $108.5M | $128.5M | $154.8M |
| Net margin | 12% | 12% | 11% | 12% | 13% | 15% |
| Earnings per share | $2.60 | $2.94 | $3.25 | $3.35 | $3.93 | $4.75 |
| Free cash flow | $118.4M | $124.4M | $89.5M | $183.8M | $182.0M | $216.6M |
| Free cash margin | 17% | 16% | 9% | 20% | 19% | 21% |
| Cash | $84.6M | $103.2M | $66.6M | $64.4M | $49.5M | $74.6M |
| Shareholders' equity | $828.2M | $877.0M | $938.3M | $1.1B | $1.1B | $1.3B |
| Shares outstanding | 32.37m | 32.29m | 32.15m | 32.25m | 32.53m | 32.06m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 23, 2026 | Quarterly ↗ | Sep 30, 2026 | 23d |
| Jul 31, 2026 | Quarterly ↗ | Jun 30, 2026 | 31d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 20, 2026 | Annual ↗ | Dec 31, 2025 | 51d |
| Oct 21, 2025 | Quarterly ↗ | Sep 30, 2025 | 21d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| Apr 24, 2025 | Quarterly ↗ | Mar 31, 2025 | 24d |
| Feb 21, 2025 | Annual ↗ | Dec 31, 2024 | 52d |
| Oct 25, 2024 | Quarterly ↗ | Sep 30, 2024 | 25d |
| Jul 26, 2024 | Quarterly ↗ | Jun 30, 2024 | 26d |
| May 3, 2024 | Quarterly ↗ | Mar 31, 2024 | 33d |
| Feb 16, 2024 | Annual ↗ | Dec 31, 2023 | 47d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 23, 2026 | Results ↗ |
| Jul 31, 2026 | Results ↗ |
| Jul 27, 2026 | Material agreement · New obligation ↗ |
| Jun 22, 2026 | Shareholder vote ↗ |
| Apr 30, 2026 | Results ↗ |
| Feb 20, 2026 | Results ↗ |
| Feb 19, 2026 | Director or officer change ↗ |
| Dec 10, 2025 | Regulation FD ↗ |
| Oct 21, 2025 | Results ↗ |
| Jul 31, 2025 | Results ↗ |
| Jun 20, 2025 | Shareholder vote ↗ |
| Apr 24, 2025 | Results ↗ |